Is tissue engineering a new paradigm in medicine? Consequences for the ethical evaluation of tissue engineering research

Medicine, Health Care and Philosophy

Volumn 12, Issue 4, 2009, Pages 459-467

  Trommelmans, Leen ^a   Selling, Joseph ^a   Dierickx, Kris ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Ethics; Paradigm; Regenerative medicine; Research; Tissue engineering

Indexed keywords

ETHICS; HUMAN; HUMAN TISSUE; REGENERATIVE MEDICINE; TISSUE ENGINEERING; ARTICLE; MEDICAL RESEARCH; ORGANIZATION AND MANAGEMENT;

BIOMEDICAL RESEARCH; HUMANS; REGENERATIVE MEDICINE; TISSUE ENGINEERING;

EID: 77952970814     PISSN: 13867423     EISSN: 15728633     Source Type: Journal    
DOI: 10.1007/s11019-009-9192-0     Document Type: Article

References (99)

1. Ahsan, T., and R.M. Nerem. 2005. Bioengineered tissues: The science, the technology, and the industry. Orthodontics and Craniofacial Research 8: 134-140.
2. Atala, A., S. Bauer, S. Soker, et al. 2006. Tissue-engineered autologous bladders for patients needing cystoplasty. The Lancet 367: 1241-1246.
3. Auger, F.A., F. Berthod, V. Moulin, et al. 2004. Tissue-engineered skin substitutes: From in vitro constructs to in vivo applications. Biotechnology and Applied Biochemistry 39: 263-275.
4. Bajada, S., I. Mazakova, J.B. Richardson, and N. Ashammakhi. 2008. Updates on stem cells and their applications in regenerative medicine. Journal of Tissue Engineering and Regenerative Medicine 2: 169-183.
5. Behfar, A., and A. Terzic. 2007. Cardioprotective repair through stem cell-based cardiopoiesis. Journal of Applied Physiology 103: 1438-1440.
6. Bock A.-K., D. Ibaretta, and E. Rodriguez-Cerezo. 2003. Human tissue-engineered products. Today’s markets and future prospects. EUR21000EN. European Commission, Brussels: JRC-IPTS.
7. Bolland, B.J., S. Tilley, A.M. New, et al. 2007. Adult mesenchymal stem cells and impaction grafting: A new clinical paradigm shift. Expert Review of Medical Devices 4: 393-404.
8. Bordenave, L., P. Menu, and C. Baquey. 2008. Developments towards tissue-engineered, small-diameter arterial substitutes. Expert Review of Medical Devices 5: 337-347.
9. Brouard, M., and Y. Barrandon. 2003. Controlling skin morphogenesis: Hope and despair. Current Opinions in Biotechnology 14: 520-525.
10. Butler, D.L., J.T. Shearn, and N. Juncosa, et al. 2004. Functional tissue engineering parameters toward designing repair and replacement strategies. Clinical Orthopaedics and Related Research 427(suppl): S190-S199.
11. Butler, D.L., N. Juncosa-Melvin, G.P. Boivin, et al. 2008. Functional tissue engineering for tendon repair: A multidisciplinary strategy using mesenchymal stem cells, bioscaffolds, and mechanical stimulation. Journal of Orthopaedic Research 26: 1-9.
12. Campbell, R., M. Evans, M. Tucker, B. Quilty, P. Dieppe, and J.L. Donovan. 2001. Why don’t patients do their exercises? Understanding non-compliance with physiotherapy in patients with osteoarthritis of the knee. Journal of Epidemiology and Community Health 55: 132-138.
13. Capi, O., and L. Gepstein. 2006. Myocardial regeneration strategies using human embryonic stem cell-derived cardiomyocytes. Journal of controlled release: Official journal of the Controlled Release Society 116: 211-218.
14. Caplan, A.I. 2007. Adult mesenchymal stem cells for tissue engineering versus regenerative medicine. Journal of Cellular Physiology 213: 341-347.
15. Chim, H., J.T. Schantz, and A.K. Gosain. 2008. Beyond the vernacular: New sources of cells for bone tissue engineering. Plastic and Reconstructive Surgery 122: 755-764.
16. Chung, C., and J.A. Burdick. 2008. Engineering cartilage tissue. Advanced Drug Delivery Reviews 60: 243-262.
17. de Vries, R.B., A. Oerlemans, and L. Trommelmans, et al. 2008. Ethical aspects of tissue engineering: A review. Tissue Engineering Part B Reviews 14. doi:10.1089/ten.teb.2008.0199.
18. Dobzhansky, T. 1973. Nothing in biology makes sense except in the light of evolution. American Biology Teacher 35: 125-129.
19. European Commission. Health and Consumer Protection Directorate-General. 2001. Opinion on the state of the art concerning tissue engineering. Adopted by the scientific committee on medicinal products and medical devices on 1st October 2001. Report No.: Doc. SANCO/SCMPMD/2001/0006Final. Available at: http://europa.eu.int/comm/food/fs/sc/scmp/out37_en.pdf. (accessed August 20, 2008).
20. European Group on Ethics. 2004. Report of the European group on Ethics on the ethical aspects of human tissue engineered products. Brussels; Report No.: 18. http://ec.europa.eu/european_group_ethics/docs/humantissueprod_en.pdf (accessed October 20, 2008).
21. European Parliament. 2007. European Parliament legislative Resolution of 25 April 2007 on the Proposal for a Regulation of the European Parliament and of the Council on Advanced Therapy Medicinal Products and Amending Directive 2001/83/EC and Regulation(EC) No 726/2004 COM(2005)0567-C6-0401/2005-2005/0227(COD) (Codecision procedure: first reading).
22. Farrugia, A. 2006. When do tissues and cells become products? Regulatory oversight of emerging biological therapies. Cell and Tissue Banking 7: 325-335.
23. Ferber, D. (1999). Lab-grown organs begin to take shape. Science 284: 422-423, 425.
24. Fernyhough, M.E., G.J. Hausman, L.L. Guan, E. Okine, S.S. Moore, and M.V. Dodson. 2008. Mature adipocytes may be a source of stem cells for tissue engineering. Biochemical and Biophysical Research Communications 368: 455-457.
25. Fiegel, H.C., P.M. Kaufmann, H. Bruns, et al. 2008. Hepatic tissue engineering: From transplantation to customized cell-based liver directed therapies from the laboratory. Journal of Cellular and Molecular Medicine 12: 56-66.
26. Fiegel, H.C., C. Lange, U. Kneser, et al. 2006. Fetal and adult liver stem cells for liver regeneration and tissue engineering. Journal of Cellular and Molecular Medicine 10: 577-587.
27. Ford, C.N. 2008. Paradigms and progress in vocal fold restoration. Laryngoscope 118: 1709-1713.
28. Frank, C.B., N.G. Shrive, R.S. Boorman, et al. 2004. New perspectives on bioengineering of joint tissues: Joint adaptation creates a moving target for engineering replacement tissues. Annals of Biomedical Engineering 32: 458-465.
29. Gates, C.B., T. Karthikeyan, F. Fu, et al. 2008. Regenerative medicine for the musculoskeletal system based on muscle-derived stem cells. The Journal of the American Academy of Orthopaedic Surgeons 16: 68-76.
30. Gerecht-Nir, S., M. Radisic, H. Park, et al. 2006. Biophysical regulation during cardiac development and application to tissue engineering. The International Journal of Developmental Biology 50: 233-243.
31. Giannoni, P., A. Crovace, M. Malpeli, et al. 2005. Species variability in the differentiation potential of in vitro-expanded articular chondrocytes restricts predictive studies on cartilage repair using animal models. Tissue Engineering 11: 237-248.
32. Ginis, I., and M.S. Rao. 2003. Toward cell replacement therapy: Promises and caveats. Experimental Neurology 184: 61-77.
33. Gordijn, B. 2004. Medizinische Utopien. Eine ethische Betrachtung. Göttingen: Vandenhoeck & Ruprecht.
34. Grayson, W.L., P.H. Chao, D. Marolt, et al. 2008. Engineering custom-designed osteochondral tissue grafts. Trends in Biotechnology 26: 181-189.
35. Hitchcock, T., and L. Niklason. 2008. Lymphatic tissue engineering: Progress and prospects. Annals of the New York Academy of Science 1131: 44-49.
36. Hollister, S.J. 2005. Porous scaffold design for tissue engineering. Nature Materials 4: 518-524.
37. Huang, G.T., W. Sonoyama, Y. Liu, et al. 2008. The hidden treasure in apical papilla: The potential role in pulp/dentin regeneration and bioroot engineering. Journal of Endodontia 34: 645-651.
38. Hutmacher, D.W., and S. Cool. 2007. Concepts of scaffold-based tissue engineering—the rationale to use solid free-form fabrication techniques. Journal of Cellular and Molecular Medicine 11: 654-669.
39. Ingber, D.E., and M. Levin. 2007. What lies at the interface of regenerative medicine and developmental biology? Development 134: 2541-2547.
40. Kim, S., and H. von Recum. 2008. Endothelial stem cells and precursors for tissue engineering: Cell source, differentiation, selection, and application. Tissue Engineering Part B Reviews 14: 133-147.
41. Knight, R.L., H.E. Wilcox, S.A. Korossis, et al. 2008. The use of acellular matrices for the tissue engineering of cardiac valves. Proceedings of the Institution of Mechanical Engineers. Part H, Journal of Engineering in Medicine 222: 129-143.
42. Kolf, C.M., E. Cho, and R.S. Tuan. 2007. Mesenchymal stromal cells. Biology of adult mesenchymal stem cells: Regulation of niche, self-renewal and differentiation. Arthritis Research and Therapy 9: 204.
43. Korossis, S., F. Bolland, E. Ingham, et al. 2006. Review: Tissue engineering of the urinary bladder: Considering structure-function relationships and the role of mechanotransduction. Tissue Engineering 12: 635-644.
44. Krampera, M., G. Pizzolo, G. Aprili, et al. 2006. Mesenchymal stem cells for bone, cartilage, tendon and skeletal muscle repair. Bone 39: 678-683.
45. Kretlow, J.D., L. Klouda, and A.G. Mikos. 2007. Injectable matrices and scaffolds for drug delivery in tissue engineering. Advanced Drug Delivery Review 59: 263-273.
46. Kuhn, T.S. 1996. The structure of scientific revolutions, 3rd ed. Chicago: The University of Chicago Press.
47. Kwan, M.D., B.J. Slater, D.C. Wan, et al. 2008. Cell-based therapies for skeletal regenerative medicine. Human Molecular Genetics 17: R93-R98.
48. Langer, R., and J.P. Vacanti. 1993. Tissue engineering. Science 260: 920-926.
49. Lilford, R., D. Braunholtz, J. Harris, et al. 2004. Trials in surgery. British Journal of Surgery 91: 6-16.
50. Lysaght, M.J., A. Jaklenec, and E. Deweerd. 2008. Great expectations: Private sector activity in tissue engineering, regenerative medicine, and stem cell therapeutics. Tissue Engineering Part A 14(2): 305-315.
51. MacNeil, S. 2007. Progress and opportunities for tissue-engineered skin. Nature 445: 874-880.
52. Marris, E. 2008. ‘Paradigm shift’ in: Disputed definitions. Nature 455: 1023-1024.
53. Mendelson, K., and F.J. Schoen. 2006. Heart valve tissue engineering: Concepts, approaches, progress, and challenges. Annals of Biomedical Engineering 34: 1799-1819.
54. Metcalfe, A.D., and M.W. Ferguson. 2008. Skin stem and progenitor cells: Using regeneration as a tissue-engineering strategy. Cellular and Molecular Life Sciences 65: 24-32.
55. Migneco, F., S.J. Hollister, and R.K. Birla. 2008. Tissue-engineered heart valve prostheses: ‘State of the heart’. Regenerative Medicine 3: 399-419.
56. Mikos, A.G., S.W. Herring, P. Ochareon, et al. 2006. Engineering complex tissues. Tissue Engineering 12(12): 3307-3339.
57. Mirensky, T.L., and C.K. Breuer. 2008. The development of tissue-engineered grafts for reconstructive cardiothoracic surgical applications. Pediatric Research 63: 559-568.
58. Moioli, E.K., P.A. Clark, X. Xin, et al. 2007. Matrices and scaffolds for drug delivery in dental, oral and craniofacial tissue engineering. Advanced Drug Delivery Review 59: 308-324.
59. Moreau, J.L., J.F. Caccamese, D.P. Coletti, et al. 2007. Tissue engineering solutions for cleft palates. Journal of Oral and Maxillofacial Surgery 65: 2503-2511.
60. Moreno-Borchart, A. 2004. Building organs piece by piece. Accomplishments and future perspectives in tissue engineering. EMBO Reports 5: 1025-1028.
61. Mummery, C. 2004. Stem cell research: Immortality or a healthy old age? European Journal of Endocrinology 151(Suppl 3): U7-U12.
62. Nadal-Ginard, B., D. Torella, and G. Ellison. 2006. Cardiovascular regenerative medicine at the crossroads. Clinical trials of cellular therapy must now be based on reliable experimental data from animals with characteristics similar to human’s. Revista española de cardiología 59: 1175-1189.
63. National Institute for Clinical Excellence (NICE). 2005. Technology Appraisal Guidance 89. The use of autologous chondrocyte implantation for the treatment of cartilage defects in knee joints. Review of Technology appraisal 16. Report No.: Technology Appraisal 16. www.nice.org.uk/TA089.
64. Nerem, R.M. 2000. Tissue engineering: Confronting the transplantation crisis. Proceedings of the Institution of Mechanical Engineers. Part H, Journal of Engineering in Medicine 214: 95-99.
65. Panetta, N.J., D.M. Gupta, B.J. Slater, et al. 2008. Tissue engineering in cleft palate and other congenital malformations. Pediatric Research 63: 545-551.
66. Panici, P.B., F. Bellati, T. Boni, et al. 2007. Vaginoplasty using autologous in vitro cultured vaginal tissue in a patient with Mayer-von-Rokitansky-Kuster-Hauser syndrome. Human Reproduction 22: 2025-2028.
67. Passier, R., and C. Mummery. 2003. Origin and use of embryonic and adult stem cells in differentiation and tissue repair. Cardiovascular Research 58: 324-335.
68. Passier, R., and C. Mummery. 2005. Cardiomyocyte differentiation from embryonic and adult stem cells. Current Opinions in Biotechnology 16: 498-502.
69. Petit-Zeman, S. 2001. Regenerative medicine. Nature Biotechnology 19: 201-206.
70. Pham, C., J. Greenwood, H. Cleland, et al. 2007. Bioengineered skin substitutes for the management of burns: A systematic review. Burns 33: 946-957.
71. Rotter, N., M. Bucheler, A. Haisch, et al. 2007. Cartilage tissue engineering using resorbable scaffolds. Journal of Tissue Engineering and Regenerative Medicine 1: 411-416.
72. Sales, K.M., H.J. Salacinski, N. Alobaid, et al. 2005. Advancing vascular tissue engineering: The role of stem cell technology. Trends in Biotechnology 23: 461-467.
73. Scott, R.C., D. Crabbe, B. Krynska, et al. 2008. Aiming for the heart: Targeted delivery of drugs to diseased cardiac tissue. Expert Opinion on Drug Delivery 5: 459-470.
74. Shah, A., J. Brugnano, S. Sun, et al. 2008. The development of a tissue-engineered cornea: Biomaterials and culture methods. Pediatric Research 63(5): 535-544.
75. Sievert, K.D., B. Amend, and A. Stenzl. 2007. Tissue Engineering for the Lower Urinary Tract: A Review of a State of the Art Approach. European Urology 52: 1580-1589.
76. Simpson, D.G. 2006. Dermal templates and the wound-healing paradigm: The promise of tissue regeneration. Expert Review of Medical Devices 3: 471-484.
77. Simpson, D.G., and G.L. Bowlin. 2006. Tissue-engineering scaffolds: Can we re-engineer mother nature? Expert Review of Medical Devices 3: 9-15.
78. Slavkin, H.C., and P.M. Bartold. 2006. Challenges and potential in tissue engineering. Periodontology 2000 41: 9-15.
79. Solchaga, L.A., V.M. Goldberg, and A.I. Caplan. 2001. Cartilage regeneration using principles of tissue engineering. Clinical Orthopaedics and Related Research (391 Suppl): S161-S170.
80. Stegemann, J.P., S.N. Kaszuba, and S.L. Rowe. 2007. Review: Advances in vascular tissue engineering using protein-based biomaterials. Tissue Engineering 13: 2601-2613.
81. Stocum, D.L. 1998. Regenerative biology and engineering: Strategies for tissue restoration. Wound Repair and Regeneration. Official publication of the Wound Healing Society [and] the European Tissue Repair Society 6: 276-290.
82. Tataria, M., S.V. Perryman, and K.G. Sylvester. 2006. Stem cells: Tissue regeneration and cancer. Seminars in Pediatric Surgery 15: 284-292.
83. Tawqeer, R., H. Salacinski, G. Hamilton, et al. 2004. The use of animal models in developing the discipline of cardiovascular tissue engineering: A review. Biomaterials 25: 1627-1637.
84. Trommelmans, L., J. Selling, and K Dierickx. 2007. Ethical issues in tissue engineering, European ethical-legal papers n°7. Leuven: Centre for biomedical ethics and law 2007. www.cbmer.be.
85. Trommelmans, L., J. Selling, and K. Dierickx. 2008a. Ethical reflections on clinical trials with human tissue engineered products. Journal of Medical Ethics 34: e1.
86. Trommelmans, L., J. Selling, and K. Dierickx. 2008b. Informing participants in clinical trials with ex vivo human tissue-engineered products: What to tell and how to tell it? Journal of Tissue Engineering and Regenerative Medicine 2: 236-241.
87. U.S. Department of Health and Human Services. 2006. 2020: A new vision—a future for regenerative medicine. www.hhs.gov/reference/newfuture.shtml (accessed October 20, 2008).
88. Vunjak-Novakovic, G., I. Martin, B. Obradovic, et al. 1999. Bioreactor cultivation conditions modulate the composition and mechanical properties of tissue-engineered cartilage. Journal of Orthopaedic Research 17: 130-138.
89. Wendt, D., M. Jakob, and I. Martin. 2005. Bioreactor-based engineering of osteochondral grafts: From model systems to tissue manufacturing. Journal of Bioscience and Bioengineering 100: 489-494.
90. Williams, D. 2006a. A registry for tissue engineering clinical trials. Medical Device Technology 17: 8-10.
91. Williams, D.F. 2006b. To engineer is to create: The link between engineering and regeneration. Trends in Biotechnology 24: 4-8.
92. Williams, D.F. 2006c. Tissue engineering: The multidisciplinary epitome of hope and despair. In Studies in multidisciplinarity, vol. 3, ed. R. Paton, and L. McNamara, 483-524. Amsterdam: Elsevier.
93. Williams, D. 2007. Cages and chondrocytes: Techniques to replace and regenerate the troublesome intervertebral disc. Medical Device Technology 18: 8-10.
94. Williams, D.F. 2008. On the mechanisms of biocompatibility. Biomaterials 29: 2941-2953.
95. Wood, J., M. Malek, F. Frassica, et al. 2006. Autologous cultured chondrocytes: Adverse events reported to the United States food and drug administration. The Journal of Bone and Joint Surgery American volume 88: 503-507.
96. Yang, J., M. Yamato, K. Nishida, et al. 2006. Cell delivery in regenerative medicine: The cell sheet engineering approach. Journal of Controlled Release: Official Journal of the Controlled Release Society 116: 193-203.
97. Zhang, Y., H.S. An, C. Tannoury, et al. 2008. Biological treatment for degenerative disc disease: Implications for the field of physical medicine and rehabilitation. American Journal of Physical Medicine & Rehabilitation/Association of Academic Physiatrists 87: 694-702.
98. Zimmermann, W.H., M. Didie, S. Doker, et al. 2006. Heart muscle engineering: An update on cardiac muscle replacement therapy. Cardiovascular Research 71: 419-429.
99. Zuk, P.A. 2008. Tissue engineering craniofacial defects with adult stem cells? Are we ready yet? Pediatric Research 63: 478-486.